Please ensure Javascript is enabled for purposes of website accessibility

Former Top Marijuana CEO Lands Surprising New Job

By Eric Volkman – Sep 18, 2019 at 6:07PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth founder Bruce Linton takes a role at Better Choice Company, among other appointments.

Canopy Growth (CGC 0.36%) founder and ex-CEO Bruce Linton has found a new job, this one in an intriguing niche of the cannabis industry. He has been appointed as special advisor to Better Choice Company, a company that specializes in cannabidiol (CBD) products for pets.

Better Choice said in a press release heralding its new hire that Linton "will be working with Better Choice to, among other things, (a) expand the Company's global cannabinoid animal research, (b) build out an internal intellectual property, data, and analytics platform, and (c) explore strategic initiatives and partnerships for the business."

Marijuana buds and vaping pen

Image source: Getty Images.

The hiring of Linton, until recently one of the highest-profile executives among the growing number of marijuana stocks, will certainly raise the profile of the previously obscure Better Choice. The company owns a small portfolio of pet wellness product lines, many of which are made with CBD.

In addition, Linton has been appointed to several non-operational positions in cannabis or cannabis-adjacent companies.

He has been named executive chairman of privately held Wolverine Partners, which describes itself as a business "curating high-quality cannabis experiences for patients in the state of Michigan and bringing internationally renowned brands to market." The company is in the midst of rebranding itself as Gage Growth Corporation.

Linton has also become a director in another enterprise that is not publicly traded, MindMed. This is an early-stage biopharmaceutical company concentrating on the development of "psychedelic inspired" treatments and therapies for ADHD and other brain-related disorders.

Bruce Linton

Image source: BruceLinton.com

Finally, Linton has taken roles as an activist investor in two companies, SLANG Worldwide and OG DNA Genetics. The former is described as "a leading global cannabis consumer packaged goods company," and the latter is a cannabis seed business.

Canopy Growth and Linton parted ways in July, as the company effectively fired him. Linton's co-CEO at the time, Mark Zekulin, stepped into the role exclusively following the departure, although this is only on an interim basis. Canopy Growth is still searching for a permanent CEO. At this stage, it seems Linton was fortunate in the timing of his exit -- subsequently, Canopy Growth released Q1 results that disappointed many investors. 

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
CGC
$2.79 (0.36%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
332%
 
S&P 500 Returns
104%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.